Yanping Yang

883 total citations
50 papers, 650 citations indexed

About

Yanping Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yanping Yang has authored 50 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Yanping Yang's work include Bone Metabolism and Diseases (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Yanping Yang is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Yanping Yang collaborates with scholars based in China, United States and Sweden. Yanping Yang's co-authors include Junli Chang, Yongjun Wang, Lin Shen, Rui Zhu, Hongshen Wang, Qi Shi, Bo Shuai, Xianyang Wang, Yanan Du and Xiaojun Yan and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Yanping Yang

48 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanping Yang China 15 395 204 141 85 55 50 650
Pinglin Lai China 16 530 1.3× 259 1.3× 148 1.0× 66 0.8× 54 1.0× 31 899
Lorraine Rose United Kingdom 12 385 1.0× 172 0.8× 133 0.9× 182 2.1× 33 0.6× 22 840
Céline Deroyer Belgium 11 387 1.0× 229 1.1× 78 0.6× 76 0.9× 30 0.5× 23 890
Zhan Liao China 9 328 0.8× 189 0.9× 109 0.8× 64 0.8× 34 0.6× 21 558
Minghao Qu China 7 297 0.8× 121 0.6× 91 0.6× 70 0.8× 26 0.5× 8 742
Edith Charlier Belgium 11 413 1.0× 224 1.1× 77 0.5× 85 1.0× 26 0.5× 15 903
Giovanna Nalesso United Kingdom 15 596 1.5× 223 1.1× 133 0.9× 138 1.6× 25 0.5× 30 1.2k
Kwang-Youl Lee South Korea 13 646 1.6× 153 0.8× 198 1.4× 63 0.7× 24 0.4× 22 832

Countries citing papers authored by Yanping Yang

Since Specialization
Citations

This map shows the geographic impact of Yanping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Yang more than expected).

Fields of papers citing papers by Yanping Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Yang. The network helps show where Yanping Yang may publish in the future.

Co-authorship network of co-authors of Yanping Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanping Yang. A scholar is included among the top collaborators of Yanping Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanping Yang. Yanping Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yanping, Kejia Hu, Karin Modig, et al.. (2024). Surgical removal of tonsils and risk of COVID-19: a nested case–control study using data from UK Biobank and AMORIS Cohort. BMC Medicine. 22(1). 460–460.
2.
Yang, Yanping, et al.. (2024). ALKBH5 modulates bone cancer pain in a rat model by suppressing NR2B expression. Biotechnology and Applied Biochemistry. 71(5). 1105–1115. 3 indexed citations
3.
Sun, Xingyuan, Junli Chang, Peng Zhao, et al.. (2024). Establishment of Patient-derived Xenograft Mouse Model with Human Osteosarcoma Tissues. Journal of Visualized Experiments.
5.
Yang, Yanping, Fatemeh Sadeghi, Maria Feychting, et al.. (2023). Risk of head and neck cancer in relation to blood inflammatory biomarkers in the Swedish AMORIS cohort. Frontiers in Immunology. 14. 1265406–1265406. 4 indexed citations
6.
Chen, Yuyang, Yuanyuan Zhang, Leilei Guo, et al.. (2023). Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers. Journal of Visualized Experiments. 2 indexed citations
7.
Yang, Yanping, et al.. (2023). Exploring the expression of SNHG1 and its effect on the PI3K-AKT axis in nasopharyngeal cancer. Neoplasma. 70(5). 670–682. 2 indexed citations
8.
Yang, Yanping, Li Yin, Qianwei Liu, et al.. (2022). Hospital-Treated Infections and Increased Risk of Two EBV-Related Malignancies: A Nested Case-Control Study. Cancers. 14(15). 3804–3804. 3 indexed citations
9.
Yang, Yanping, Pan Liang, Yiying Huang, et al.. (2022). Aberrant inactivation of SCNN1G promotes the motility of head and neck squamous cell carcinoma. Pathology - Research and Practice. 240. 154175–154175. 2 indexed citations
10.
Chang, Junli, Hongfeng Ruan, Xiaobo Wang, et al.. (2021). Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation. International Journal of Biological Sciences. 17(10). 2504–2522. 26 indexed citations
11.
Zhao, Weilin, Bo Li, Peipei Han, et al.. (2021). Epigenetic Inactivation of Acetyl-CoA Acetyltransferase 1 Promotes the Proliferation and Metastasis in Nasopharyngeal Carcinoma by Blocking Ketogenesis. Frontiers in Oncology. 11. 667673–667673. 17 indexed citations
12.
Wang, Yi-Fang, Xiaohui Zhou, Peipei Han, et al.. (2021). Inverse correlation of miR-27a-3p and CDH5 expression serves as a diagnostic biomarker of proliferation and metastasis of clear cell renal carcinoma. Pathology - Research and Practice. 220. 153393–153393. 7 indexed citations
13.
Chang, Junli, et al.. (2021). Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models. Journal of Visualized Experiments. 4 indexed citations
14.
Zhang, Shuxian, Yanping Yang, Yi Tang, et al.. (2021). Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis. Medical Oncology. 38(9). 111–111. 1 indexed citations
15.
Luo, Qiang, Panpan Xian, Tian Wang, et al.. (2021). Antioxidant activity of mesenchymal stem cell-derived extracellular vesicles restores hippocampal neurons following seizure damage. Theranostics. 11(12). 5986–6005. 69 indexed citations
16.
Yan, Xiaojun, Kun Zhang, Yanping Yang, et al.. (2020). Dispersible and Dissolvable Porous Microcarrier Tablets Enable Efficient Large-Scale Human Mesenchymal Stem Cell Expansion. Tissue Engineering Part C Methods. 26(5). 263–275. 50 indexed citations
17.
Wu, Xianping, et al.. (2018). MicroRNA-365 alleviates morphine analgesic tolerance via the inactivation of the ERK/CREB signaling pathway by negatively targeting β-arrestin2. Journal of Biomedical Science. 25(1). 10–10. 23 indexed citations
18.
Wang, Wenyi, Junli Chang, Hongfeng Ruan, et al.. (2018). Down-Regulated microRNA-34a Expression as a Prognostic Marker for Poor Osteosarcoma in Mice: A Systematic Review and Meta-Analysis. Journal of Cancer. 9(22). 4179–4186. 5 indexed citations
19.
Shuai, Bo, Rui Zhu, Yanping Yang, et al.. (2016). Positive Effects of Qing’e Pill (青娥丸) on Trabecular Microarchitecture and its Mechanical Properties in Osteopenic Ovariectomised Mice. Chinese Journal of Integrative Medicine. 25(4). 270–277. 9 indexed citations
20.
Li, Wenjun, et al.. (2014). The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis. World Journal of Surgical Oncology. 12(1). 55–55. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026